We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
-4.21%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$121M
AUM Growth
-$12.5M
Cap. Flow
-$6.4M
Cap. Flow %
-5.31%
Top 10 Hldgs %
74.38%
Holding
590
New
27
Increased
162
Reduced
81
Closed
24

Top Buys

Rank Stock Value
1
PRLB icon
Protolabs
PRLB
+$145K
2
SCTL
Societal CDMO, Inc. Common Stock
SCTL
+$111K
3
ATRC icon
AtriCure
ATRC
+$87.8K
4
TNDM icon
Tandem Diabetes Care
TNDM
+$78.8K
5
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$67.8K

Top Sells

Rank Stock Value
1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$2.16M
2
KRYS icon
Krystal Biotech
KRYS
+$2.02M
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$637K
4
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$584K
5
HALO icon
Halozyme
HALO
+$430K

Sector Composition

Rank Sector Weight
1 Healthcare 7.9%
2 Financials 4.48%
3 Technology 3.39%
4 Consumer Discretionary 2.75%
5 Industrials 1.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNN icon
476
Smith & Nephew
SNN
$13.5B
$1.61K ﹤0.01%
65
-24
-27% -$674
MSCI icon
477
MSCI
MSCI
$41.8B
$1.54K ﹤0.01%
3
– –
VTNR
478
DELISTED
Vertex Energy, Inc
VTNR
$1.53K ﹤0.01%
345
– –
PLUG icon
479
Plug Power
PLUG
$2.9B
$1.52K ﹤0.01%
200
– –
RIOT icon
480
Riot Platforms
RIOT
$8.1B
$1.49K ﹤0.01%
160
– –
HIMX
481
Himax Technologies
HIMX
$2.23B
$1.49K ﹤0.01%
254
+14
+6% +$90
FHLC icon
482
Fidelity MSCI Health Care Index ETF
FHLC
$3.28B
$1.48K ﹤0.01%
24
-3
-11% -$189
RTX icon
483
RTX Corp
RTX
$292B
$1.44K ﹤0.01%
20
– –
TSCO icon
484
Tractor Supply
TSCO
$16.8B
$1.42K ﹤0.01%
35
-10
-22% -$433
MRK icon
485
Merck
MRK
$316B
$1.4K ﹤0.01%
14
+1
+8% +$108
ONON icon
486
On Holding
ONON
$12.6B
$1.36K ﹤0.01%
49
+20
+69% +$633
AIQ icon
487
Global X Artificial Intelligence & Technology ETF
AIQ
$10.5B
$1.35K ﹤0.01%
+50
New +$1.41K
SE icon
488
Sea Limited
SE
$68.1B
$1.32K ﹤0.01%
30
– –
OCUL icon
489
Ocular Therapeutix
OCUL
$1.84B
$1.25K ﹤0.01%
397
– –
YMAB
490
DELISTED
Y-mAbs Therapeutics
YMAB
$1.2K ﹤0.01%
220
– –
AXGN icon
491
Axogen
AXGN
$2.46B
$1.18K ﹤0.01%
235
-2,000
-89% -$13.8K
CGC
492
Canopy Growth
CGC
$404M
$1.17K ﹤0.01%
150
– –
EELV icon
493
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$428M
$1.16K ﹤0.01%
52
+1
+2% +$24
SND icon
494
Smart Sand
SND
$186M
$1.16K ﹤0.01%
500
– –
INFY icon
495
Infosys
INFY
$49.6B
$1.15K ﹤0.01%
67
– –
DOL icon
496
WisdomTree True Developed International Fund
DOL
$832M
$1.14K ﹤0.01%
25
– –
EXEL icon
497
Exelixis
EXEL
$13.8B
$1.11K ﹤0.01%
51
– –
CHPT icon
498
ChargePoint
CHPT
$143M
$1.11K ﹤0.01%
11
– –
CARR icon
499
Carrier Global
CARR
$52.1B
$1.1K ﹤0.01%
20
– –
MSI icon
500
Motorola Solutions
MSI
$72.6B
$1.09K ﹤0.01%
4
– –
18 19
20
21 22

Similar funds

IRP
Investment Research Partners Lemont, Pennsylvania $246M AUM
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return
KC
Kinloch Capital Glen Allen, Virginia $245M AUM 18.26% 1-Year Est. Return
HA
Hanover Advisors Seneca, South Carolina $246M AUM 12.74% 1-Year Est. Return

HighMark Wealth Management's Q3 2023 Portfolio in Review

As of Q3 2023, HighMark Wealth Management held 590 positions worth $121M, down 9.4% from $133M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

HighMark Wealth Management withdrew a net $6.4M in Q3 2023, closing 24 positions and reducing 81 holdings. Its most notable exit was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $2.16M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.9% of assets, down from 12% a quarter earlier, followed by Financials and Technology.

Against the trend, HighMark Wealth Management opened a new position in Insulet worth $19.9K.

  • HighMark Wealth Management's largest Q3 2023 buy was Insulet: 125 shares worth $19.9K.
  • HighMark Wealth Management added most to Protolabs in Q3 2023, an estimated $145K increase.
  • HighMark Wealth Management's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $637K.
  • HighMark Wealth Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $2.16M.
  • HighMark Wealth Management's ten largest holdings make up 74% of its $121M portfolio in Q3 2023.
  • HighMark Wealth Management opened 27 new positions and closed 24 in Q3 2023.
  • HighMark Wealth Management's portfolio value fell 9.4% quarter-over-quarter to $121M.

Based on HighMark Wealth Management's 13F filing for Q3 2023, filed 18 Oct 2023.